Verano Holdings (VRNO) Divestments (2021 - 2025)
Verano Holdings' (VRNO) quarterly Divestments came in at $9.1 million in Q1 2025, up 3528.4% on a QoQ basis from $250000.0 in Q3 2022.
Verano Holdings (VRNO) Divestments (2021 - 2025) Analysis & Trends
Verano Holdings (VRNO) has 3 years of Divestments data on file, last reported at $9.1 million in Q1 2025.
- On a quarterly basis, Divestments changed N/A year-over-year to $9.1 million in Q1 2025; TTM through Dec 2025 was $9.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $9.1 million, changed N/A from the prior year.
- Divestments for Q1 2025 stood at $9.1 million, up from $250000.0 in the prior quarter.
- Over the last five years, Divestments for VRNO reached as high as $19.8 million in Q1 2022 and fell as low as -$10.3 million in Q4 2021.
- Historically, Divestments has averaged $3.7 million across 3 years, with a median of $250000.0 in 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 42.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.28 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 63.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 9.07 Mn |
| Sep 30, 2022 | 250,000.00 |
| Jun 30, 2022 | -245,000.00 |
| Mar 31, 2022 | 19.82 Mn |
| Dec 31, 2021 | -10.28 Mn |